Amritpal Khela, MD
Family Medicine · Bedford, TXNPI 1831659507
Payments from drug & device makers
Across 84 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$209
- Novo Nordisk$192
- Exact Sciences$154
- Bayer$147
- AstraZeneca$120
- Boehringer Ingelheim$119
- plus $578 from 15 others
What the payments were for
- Food & beverage$1,49999%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 13 | $209 |
| Novo Nordisk | 11 | $192 |
| Exact Sciences | 7 | $154 |
| Bayer | 9 | $147 |
| AstraZeneca | 6 | $120 |
| Boehringer Ingelheim | 7 | $119 |
| GSK | 6 | $118 |
| AbbVie | 4 | $66 |
| Abbott | 3 | $57 |
| Pfizer | 3 | $46 |
| Sanofi Pasteur Inc. | 2 | $44 |
| Scilex Pharmaceuticals Inc. | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $40 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Medtronic | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Cipher Pharmaceuticals US LLC | 1 | $21 |
| Halozyme Inc | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Amgen | 1 | $14 |
How this compares
$1,519 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 85 | $985 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $837 |
| Levothyroxine Sodium | 43 | $347 |
| Metformin Hcl | 37 | $313 |
| Rosuvastatin Calcium | 35 | $310 |
| Fluticasone Propionate | 23 | $301 |
| Gabapentin | 17 | $287 |
| Losartan Potassium | 31 | $286 |
| Amlodipine Besylate | 57 | $255 |
| Pantoprazole Sodium | 11 | $251 |
| Metoprolol Succinate | 14 | $251 |
| Amitriptyline Hcl | 12 | $214 |
| Lisinopril | 33 | $163 |
| Trazodone Hcl | 14 | $159 |
| Triamcinolone Acetonide | 12 | $142 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bedford
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.